Does metabolic syndrome influence short and long term durability of carotid endarterectomy and stenting?
<br/><strong>Aims: </strong>The metabolic syndrome (MetS) is composed of a cluster of related cardiovascular risk factors. The aim of the present study was to determine how MetS contributes to short‐ (30‐day) and long‐term complications and restenosis after carotid endarterectomy (...
Main Authors: | Casana, R, Malloggi, C, Tolva, V, Odero, A, Bulbulia, R, Halliday, A, Silani, V |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2018
|
Similar Items
-
Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre
by: Casana, R, et al.
Published: (2018) -
Antiplatelet therapy in carotid artery stenting and carotid endarterectomy in the asymptomatic carotid surgery trial-2
by: Huibers, A, et al.
Published: (2015) -
Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
by: Giannoukas, A, et al.
Published: (2014) -
The Asymptomatic Carotid Surgery Trial-2 (ACST-2): An ongoing randomised trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke
by: Bulbulia, R, et al.
Published: (2017) -
Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time.
by: Lokuge, K, et al.
Published: (2017)